Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Fisher Scientific Expands Access to Peanut Allergy Tests

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
The Thermo Scientific ImmunoCAP peanut component tests are now available through the co-marketing and distribution collaboration with Quest Diagnostics.

Quest Diagnostics is the first national diagnostic information services provider to broadly offer diagnostic services based on the ImmunoCAP tests to physicians, significantly broadening patient access. Under a non-exclusive agreement, the two companies will also co-market ImmunoCAP test services provided by Quest Diagnostics’ clinical laboratories. Additional terms were not disclosed.

“Quest Diagnostics has long-standing expertise with ImmunoCAP technologies. The addition of the ImmunoCAP Peanut Component Tests to Quest’s ImmunoCAP menu extends physician and patient access to these important diagnostic tools,” said Joseph Bernardo, president, immunodiagnostics, for Thermo Fisher Scientific. “The more that patients, in consultation with their doctors, know about their specific exposure risks to peanut allergens, the safer they and their families may be from this potential health risk.”

Unlike skin scratch testing, the ImmunoCAP Peanut Component tests measure a patient’s Immunoglobulin E, or IgE, sensitization to five important individual peanut proteins, called allergen components. Some of these components are known to be responsible for severe allergic reactions in sensitized patients. Physicians may use this information to identify patients who have a good chance of passing an oral food challenge and to develop personalized treatment plans tailored to a patient’s individual risk.

Peanuts and tree nuts are the most common cause of fatal and near-fatal allergic reactions to food in the United States. A Quest Diagnostics Health Trends study published in 2011 found that peanuts were the most common source of food allergen sensitization in children ages six to 18 years of age, affecting nearly one in four tested by the company.

While some peanut sensitized patients may react to components in the peanut that can cause severe and potentially life-threatening reactions, other patients may react only to components that usually cause only mild localized reactions. Results from peanut component testing can help to stratify a patient’s risk and identify those patients likely to pass an oral food challenge.

“Many parents fear that their children may be at risk of a severe allergic reaction to peanuts, and these children often live restricted lives as a result,” said Stanley J. Naides, M.D., medical director, Immunology R&D, Quest Diagnostics. “ImmunoCAP component technology takes peanut allergy testing to the next level, providing not only the ability to identify allergen sensitization but may also help physicians predict the likelihood of a systemic reaction upon allergen exposure. That’s the kind of critical diagnostic insight that can empower patients and create a healthier world.”

Other ImmunoCAP blood allergy tests available to physicians through Quest Diagnostics include component testing for milk, egg and respiratory allergens.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher, Cytonome/ST Announce Partnership
Partnership aims to focus on the development of a new line of flow cytometry cell sorting platforms.
Tuesday, June 28, 2016
Thermo Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2016
International competition rewards three top proteomics researchers for outstanding innovation and impact.
Thursday, June 09, 2016
Native Mobile Capabilities Added to Thermo SampleManager
One of world’s most widely deployed LIMS continues to add functionality that modern labs require.
Monday, March 14, 2016
Thermo, Children’s Hospital Los Angeles Partner
Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA’s first NGS panel designed to target biomarkers associated with childhood cancers.
Friday, February 19, 2016
Thermo Scientific Gemini Handheld Chemical Analyzer Wins R&D 100 Award
Two-in-one portable device also earns Editor’s Choice in Analytical/Test category for 2015 by R&D Magazine.
Thursday, November 26, 2015
Thermo Scientific Signs Agreement with Novartis, Pfizer
Universal test designed for non-small cell lung cancer supports multiple drug development programs.
Thursday, November 26, 2015
Thermo Scientific Opens New GMP Clinical Services Facility in Singapore
New regional BioPharma Services hub offers larger operational space and advanced equipment to meet increasing clinical supply needs for pharma and biotech customers.
Saturday, November 21, 2015
Thermo Scientific Manufacturing Site to Meet Guidelines for 18385 Certification
A new standard proposed by the International Organization for Standardization.
Thursday, October 15, 2015
Thermo Fisher Scientific Announces Winners of 2016 Winter Conference Awards in Plasma Spectrochemistry
Independent committee recognizes significant contributions in plasma spectrochemistry.
Wednesday, September 23, 2015
Thermo Fisher Scientific Receives IVDD CE Mark for LC-MS Products
Now available to clinical laboratories in Europe for general in vitro diagnostic use.
Friday, September 11, 2015
Thermo Launches Geneticon
Thermo Fisher Scientific launches GenetiCon, a virtual resource showcasing the real-life science behind superheroic powers and more.
Tuesday, July 07, 2015
Thermo Fisher Agrees to Buy Alfa Aesar for $403M
The company announced a definitive agreement to buy the research chemical manufacturer for $403 million.
Friday, June 26, 2015
Ebola Sequencing Data Released to Global Research Community Online
To curb further spread of Ebola in Sierra Leone, a team of scientists that is part of an international, multi-organizational effort has released their first dataset of the virus’ genetic structure online.
Wednesday, June 03, 2015
Thermo's NGS Platform Selected for Nationwide Clinical Research Program
National Cancer Institute-MATCH trial to sequence thousands of tumor samples using Ion Torrent targeted sequencing technology.
Monday, June 01, 2015
Thermo Strengthens Bioprocessing Offering with Advanced Scientifics Acquisition
Thermo Fisher Scientific has acquired Advanced Scientifics, Inc., a global provider of single-use technologies for customized bioprocessing solutions, for $300 million in cash.
Friday, February 06, 2015
Scientific News
Open Source Seed Initiative – A Welcome Boost to Global Crop Breeding
A team of plant breeders, farmers, non-profit agencies, seed advocates, and policymakers have created the Open Source Seed Initiative.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Anthrax Proteins Might Help Treat Cancerous Tumors
Studies in mice reveal novel treatment regimen.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
HIV Structure Stabilized
Findings represent ‘big accomplishment’ in biomedical engineering and design.
Four Newly-Identified Genes Could Improve Rice
A Japanese research team have applied a method used in human genetic analysis to rice and rapidly discovered four new genes that are potentially significant for agriculture. These findings could influence crop breeding and help combat food shortages caused by a growing population.
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Antibodies To Dengue May Alter Course Of Zika Virus Infection
Scientists at Emory Vaccine Center, in collaboration with investigators from Thailand, have found that people infected with dengue virus develop antibodies that cross-react with Zika virus.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!